ABL Bio Inc. (KOSDAQ:298380)

ABL Bio Revenue

ABL Bio had revenue of 13.14B KRW in the quarter ending March 31, 2026, with 506.83% growth. This brings the company's revenue in the last twelve months to 90.32B, up 226.89% year-over-year. In the year 2025, ABL Bio had annual revenue of 79.35B with 137.55% growth.

• Revenue (ttm): 90.32B
• Revenue Growth: +226.89%
• P/S Ratio: 56.47
• Revenue / Employee: 885.50M
• Employees: 102
• Market Cap: 5.10T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	79.35B	45.95B	137.55%
Dec 31, 2024	33.40B	-32.14B	-49.04%
Dec 31, 2023	65.55B	-1.75B	-2.61%
Dec 31, 2022	67.30B	61.97B	1,162.19%
Dec 31, 2021	5.33B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error